Leerink partners, TD Cowen, and William Blair initiated coverage and set ratings for Kailera Therapeutics.

The entities involved

• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
• Leerink partners →

  U.S. investment bank

  • Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52
  • A filing required by the SEC concerning McKesson Corporation shares, accompanied by analyst commentary.Sun 22:38

Related events

• Leerink Partners started coverage on ANI Pharmaceuticals shares.Sep 9
• TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.Jul 18
• Lakefront Biotherapeutics (LKFT) is trading on Nasdaq as various financial firms issue rating updates, including a buy rating from TD Cowen and price target cuts from Morgan Stanley and RBC.Sep 17
• Needham & Company issued a buy rating, and Leerink Partners began coverage of Collegium Pharmaceutical, Inc. on September 23, 2026.Wed 13:21
• TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.Aug 27